| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0027-9684(15)31180-9 |
| P698 | PubMed publication ID | 18277814 |
| P50 | author | Ebru Koca | Q79342119 |
| P2093 | author name string | Yavuz Beyazit | |
| Hakan Goker | |||
| Ibrahim C Haznedaroglu | |||
| Yahya Buyukasik | |||
| Salih Aksu | |||
| Kadir Acar | |||
| Nilgün Sayinalp | |||
| Osman I Ozcebe | |||
| Serafettin Kirazli | |||
| Deniz Cetiner | |||
| P2860 | cites work | Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis | Q77768132 |
| Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis | Q78560054 | ||
| Abnormal vascular, platelet and coagulation markers in primary thrombocythaemia are not reversed by treatments that reduce the platelet count | Q81473374 | ||
| Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V | Q24293698 | ||
| Effects of stent coating on platelets and endothelial cells after intracoronary stent implantation | Q28176313 | ||
| Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation | Q28187729 | ||
| Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts | Q28196349 | ||
| Human platelet glycoprotein V: a surface leucine-rich glycoprotein related to adhesion | Q28291698 | ||
| Increased thrombin responsiveness in platelets from mice lacking glycoprotein V | Q28586401 | ||
| Selectins and IL-6 during the clinical course of idiopathic thrombocytopenic purpura | Q33328224 | ||
| Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis | Q33336747 | ||
| Plasma thrombospondin in immune thrombocytopenic purpura. | Q33341779 | ||
| Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions | Q33344528 | ||
| Thrombocytopenia complicating the clinical course of leptospiral infection | Q33345444 | ||
| Bone marrow and peripheral blood C-kit ligand concentrations in patients with thrombocytosis and thrombocytopenia. | Q33358037 | ||
| Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura | Q33359826 | ||
| Varicella-associated thrombocytopenia: autoantibodies against platelet surface glycoprotein V. | Q33497451 | ||
| Activated platelet aggregates in thrombotic thromboctyopenic purpura: decrease with plasma infusions and normalization in remission | Q33497622 | ||
| Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura | Q33504478 | ||
| A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. | Q34106615 | ||
| Pathologic thrombopoiesis of rheumatoid arthritis | Q35084709 | ||
| Assessment of platelet activation in myeloproliferative disorders with complementary techniques | Q44827234 | ||
| Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera | Q47416647 | ||
| Platelet activation by antiplatelet autoantibodies in immune thrombocytopenic purpura | Q67554691 | ||
| Platelet membrane glycoprotein V: characterization of the thrombin-sensitive glycoprotein from human platelets | Q69958720 | ||
| Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia | Q71096713 | ||
| Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis | Q71475041 | ||
| Interleukin-1 beta and interleukin-6 in clonal versus reactive thrombocytosis | Q71572893 | ||
| Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity | Q71579102 | ||
| Megakaryocytopoietic cytokines in autoimmune thrombocytopenic purpura | Q71857275 | ||
| Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes | Q73012008 | ||
| The significance and distinct interactions of various growth factors in physiologic and pathologic megakaryocytopoiesis/thrombocytopoiesis | Q73327368 | ||
| Haematopoietic cytokines and increased megakaryocytic proliferation in chromosome 5q deletion | Q73354495 | ||
| Thrombosis and hemorrhage in chronic myeloproliferative disorders | Q73567900 | ||
| Increased plasma levels of soluble platelet glycoprotein V in patients with acute myocardial infarction | Q73794559 | ||
| Down-regulation and redistribution of GPV/GPVf2, a subunit of von Willebrand factor receptor (GPIb/IX/V complex), on the surface membrane of thrombin-stimulated human platelets | Q74459485 | ||
| Circulating thrombopoietin in clonal versus reactive thrombocytosis | Q74597209 | ||
| Albendazole-induced amegakaryocytic thrombocytopenic purpura | Q74815585 | ||
| Cloning and characterization of the gene encoding the murine glycoprotein V: the conserved thrombin-cleavable protein on platelet surface | Q77448501 | ||
| In vivo platelet and T-lymphocyte activities during pulmonary tuberculosis | Q77759087 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 86-90 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Journal of the National Medical Association | Q15752322 |
| P1476 | title | Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis | |
| P478 | volume | 100 |
Search more.